Revenue Recognition (Tables)

12 Months Ended

Dec. 31, 2023

Revenue Recognition

Schedule of disaggregation of revenues by payer types

	Year Ended December 31,
	2023		2022		2021
	(in thousands)
Insurance carriers	$	954,155	$	690,754	$	492,563
Laboratory partners		98,891		94,910		100,019
Patients		29,525		34,558		32,904
Total revenues	$	1,082,571	$	820,222	$	625,486

Schedule of total revenue by geographic area

	Year ended December 31,
	2023		2022		2021
	(in thousands)
United States	$	1,047,636	$	785,849	$	590,872
Americas, excluding U.S.		4,908		3,705		4,047
Europe, Middle East, India, Africa		22,811		16,640		20,429
Asia Pacific and Other		7,216		14,028		10,138
Total	$	1,082,571	$	820,222	$	625,486

Schedule of beginning and ending balances of accounts receivable and deferred revenues

	Balance at		Balance at
	December 31,		December 31,
	2023		2022
	(in thousands)
Assets:
Accounts receivable	$	278,289	$	244,385
Liabilities:
Deferred revenue, current portion	$	16,612	$	10,777
Deferred revenue, long-term portion		19,128		20,001
Total deferred revenues	$	35,740	$	30,778

Schedule of changes in the balance of deferred revenues

	Balance at		Balance at
	December 31,		December 31,
	2023		2022
	(in thousands)
Beginning balance	$	30,778	$	28,722
Increase in deferred revenues		35,573		28,978
Reclasses from deferred revenues to other short-term liabilities		(522)		(337)
Revenue recognized during the period that was included in deferred revenues at the beginning of the period		(10,564)		(8,782)
Revenue recognized from performance obligations satisfied within the same period		(19,525)		(17,803)
Ending balance	$	35,740	$	30,778